1/70
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
GIT DISORDERS
Peptic Ulcer Disease
Constipation & Diarrhea
IBS, IBD
Emesis
Stomach wall
The mucosal layer protects the stomach from acid.
If damaged, it exposes the underlying tissue to gastric acid.
This can lead to open sores in the stomach lining → Peptic Ulcer Disease (PUD).
Physiology of gastric acid secretion
• Gastric acid is secreted by the PROTON PUMP in the PARIETAL cells
• H⁺/K⁺-ATPase
• Stimulated by:
ACETYLCHOLINE
HISTAMINE (H2)
GASTRIN
• Gastric acid secretion is inhibited by PG/PROSTAGLANDIN, which stimulate HCO3- and MUCUS by epithelial cells
PEPTIC ULCER DISEASE
Damage to the MUCOUS MEMBRANE normally protects the esophagus, stomach, and duodenum from GASTRIC ACID and PEPSIN
PEPTIC ULCER DISEASE
Causes
• Microbe: H. Pylori
• NSAIDs
• Alcohol
• Stress
Gastric Ulcer
An ulcer in the stomach is called
Duodenal ulcer
Damage in the first part of the small intestine, the duodenum is called
Aggressive factors
Acid (HCl)
Pepsin
Bile acid
NSAIDs
H. Pylori
Defensive factors
Prostaglandin/PG
HCO3-
Mucus
Goal of Therapy for PUD
Decrease acid secretion
Increase cytorotection (defensive factors)
Eradicate H. Pylori (monotherapy is not allowed)
Eradicate H. pylori
Triple Therapy
PPIs (pantoprazole)
Clarithromycin
Amoxicillin; Metronidazole
Eradicate H. pylori
Quadruple Therapy:
Non-Bismuth therapy
PPI (+ 3 antimicrobials)
→ Rabeprazole plus amoxicillin, clarithromycin, and metronidazole
Bismuth-based therapy
PPIs
Metronidazole
Tetracycline
Bismuth subsalicylate
Reduce Gastric Secretion
H₂-blockers
Proton Pump Inhibitors (PPIs)
Antacids
H₂-blockers
MOA
Inhibition of Histamine 2 receptor = decrease cAMP = decrease gastric acid secretion
-tidine
Drugs
Cimetidine
weak anti-androgen (can cause gynecomastia), enzyme inhibitor
Ranitidine
Famotidine
most Fotent
Nizatidine
nicely absorbed → most bioavailable H2 Blocker
Proton Pump Inhibitors (PPIs)
MOST IMPORTANT DRUGS FOR ULCER; DOC
MOA
Reduce stomach acid production by irreversibly blocking the H+/K+-ATPase enzyme (also known as the proton pump) in the parietal cells of the stomach.
This enzyme is the final step in the acid secretion process.
By blocking, ↓ acid secretion
Drugs
Omeprazole
1st PPI
Rabeprazole
Pantoprazole
Esomeprazole
***NOTE THAT ARIPIPRAZOLE IS AN ATYPICAL ANTIPSYCHOTIC DRUG
Proton Pump Inhibitors (PPIs)
Preferred drugs for:
PUD (NSAIDs, stress, H. Pylori
Zollinger - Ellison (pancreatic tumor - gastrinoma)
GERD
Dyspepsia (indigestion)
Advantage:
Increase efficacy as compared to others
Shorter course of therapy
Antacids
MOA
Act as CHEMICAL ANTAGONIST (neutralizers of HCl)
Remember: they do not act on receptors, they act as neutralizers
Drugs
NaHCO₃ - systemic antacid
Can cause rebound hyperacidity, metabolic alkalosis, edema ⭐
Al(OH)₃ - non systemic antacid
Constipation
Mg(OH)₂ - non systemic antacid
Diarrhea
CaCO₃ - non systemic antacid
Constipation
Remember:
• Ala Ca Tae - Constipation
• Mg Tae - Diarrhea
Enhance cytoprotection
Enhance protection of the gastric mucosa from becoming inflammed and necrotic on being exposed to noxious agents.
Sucralfate
Misoprostol
Sucralfate
Polymer of sulfated sucrose and aluminum hydroxide
A/E: Constipation
Misoprostol
MOA: “dual action”
a. Parietal cells
(+) Activate Prostaglandin receptor → ↓ decrease cAMP → ↓ Decrease Acid secretion
b. Epithelial cells
↑ Increase Bicarbonate (HCO₃⁻) & mucus secretion → ↑ Increase Mucosal protection
Use:
NSAID-induced ulcers (especially in high-risk patients)
Adverse Effects (A/E):
Diarrhea
Intestinal cramping
Uterine contraction → May lead to abortion (contraindicated in pregnancy)
CONSTIPATION
• Difficult passage of stool
• Infrequent bowel movement
Cause:
LOW PERISTALSIS MOVEMENT
INADEQUATE FIBER INTAKE
DRUG INDUCED (morphine, antacid)
DEHYDRATION
LACK OF PHYSICAL ACTIVITY
Laxatives
increase bowel movements/peristalsis and facilitate defecation
True
Laxatives and cathartics both promote bowel movements, but cathartics have a stronger, more forceful effect, causing more rapid and watery evacuation of the colon, while laxatives generally produce a milder effect.
Laxatives
Classification (based on MOA)
Bulk-Forming Laxatives
Emollient Laxatives
Osmotic Laxatives
Stimulant (Secretory) Laxatives
Lubricant laxatives
Bulk-Forming Laxatives
• Increase the size of fecal matter
• Recommendation
1 glass of water to ensure adequate hydration and to avoid intestinal obstruction
• SAFEST and MOST FUNCTIONAL type of laxative
• Preferred in CHRONIC CONSTIPATION
• Examples:
Fibers
Psyllium
Polycarbophil
Emollient Laxatives
• AKA STOOL SOFTENERS
because they facilitate the incorporation of water into fatty intestinal material (ACT AS SURFACTANTS)
• Examples:
Docusate (Na, K, Ca)
Osmotic Laxatives
Help relieve constipation by drawing water into the colon through osmosis, softening the stool and making it easier to pass
Osmotic Laxatives
Salts
Short-term use only
a. MgSO₄
b. MgO
c. Na₃PO₄
Osmotic Laxatives
Sugars (nonelectrolytes)
Long-term use
a. Lactulose
b. PEG
Lactulose
• Hydrolysis:
Lactulose → Gal + Fru
• Fermentation:
Lactulose → Acetic Acid + Lactic Acid
• Use:
Cathartic, portal-systemic encephalopathy
Stimulant (Secretory) Laxatives
• AKA secretory laxatives
• Act directly on the intestinal mucosa to alter fluid secretion and stimulate peristalsis
• Examples:
Castor oil (Ricinoleic acid)
Anthraquinone glycosides
Cascara sagrada
Senna
Synthetic: bisacodyl
A/E
Abdominal cramping
Electrolyte imbalance
Chronic:
Dependence
Melanosis coli (blackening of colon)
Cathartic colon
Lubricant laxatives
• Lubricate the stool surface resulting in smooth passage of fecal contents
• Example: Mineral oil
• A/Es and DI:
Lipid pneumonitis
Aspiration pneumonia
Mineral oil + Fat Soluble Vit (ADEK) = deceeased absorption of ADEK
Prescription medications for Constipation
Methylnaltrexone
Lubiprostone
Lactulose
Methylnaltrexone
Approved for the management of opioid induced constipation
Lubiprostone
Chloride channel activator
For irritable bowel syndrome - constipation, chronic idiopathic constipation, for opioid induced constipation
Lactulose
For hepatic encephalopathy
Lactulose is a non-absorbable disaccharide
Reaches the colon → fermented by bacteria → produces lactic acid & acetic acid
This acidifies the colon, converting ammonia (NH₃) to ammonium (NH₄⁺)
NH₄⁺ is non-absorbable and excreted in stool
↓ ammonia levels in the blood
DIARRHEA
• Increase frequency and liquidity of bowel movements
• Increase peristalsis
• LBM - loose, watery stool
• Factors:
Food poisoning (infections)
Food intolerance
Drug - MgSO4, Mg(OH)2
• Goal: Decrease peristalsis movement
ANTIDIARRHEAL DRUGS
Opioid Drugs
Eluxadoline
Locally Acting Drugs
Bismuth subsalicylate
Anti-microbials
Opioid Drugs
• Most efficacious antidiarrheal drugs
• MOA: (+) Activate mu (μ) receptors in smooth muscle → decrease peristalsis
• Examples:
Loperamide
Diphenoxylate
Eluxadoline
Eluxadoline
IBS-diarrhea (IBS-D)
Locally Acting Drugs
Psyllium hydrophilic mucilloid
Calcium polycarbophil
Both are adsorbents
Bismuth subsalicylate
• Appears to produce its antidiarrheal effect by inhibiting intestinal secretions
• Most effective in treating infectious diarrhea
Bacteria causing diarrhea
• Traveler’s diarrhea (E. coli)
• Clostridium difficile colitis
• Amebiasis (E. histolytica)
• Rice-watery diarrhea (V. cholerae)
Traveler’s diarrhea (E. coli)
“ETEC”
Co-Trimoxazole
Quinolones (Fluoroquinolones - Ciprofloxacin)
Clostridium difficile colitis
Px will suffer from bloody diarrhea
Metronidazole
Oral Vancomycin
Fidaxomicin
Amebiasis (E. histolytica)
Metronidazole
Rice-watery diarrhea (V. cholerae)
Tetracycline
IRRITABLE BOWEL SYNDROME
Common problem in the large intestine
Chronic abdominal pain intestinal spasms altered bowel habits
IRRITABLE BOWEL SYNDROME
Symptoms
Cramping
Abdominal pain
Diarrhea and/or constipation
Anti-spasmodic agents
Refers to drugs designed to relieve or prevent spasms of the gastrointestinal tract, primarily used in patients with symptoms consistent with irritable bowel syndrome (IBS)
Dicyclomine (Dicycloverine)
Hyoscyamine
Hyoscine = Scopolamine
Natural: Peppermint Oil
Loperamide
Tx for Mild IBS-D:
Polyethylene glycol (PEG)
Tx for Mild IBS-C:
IBS-CONSTIPATION
Tegaserod
Lubiprostone
Linaclotide
Tegaserod
• 5-HT4 agonist = ↑ peristalsis
• Reserved drug due to CVD
Lubiprostone
• (+) Chloride channel activator = ↑Cl = ↑ peristalsis
• A/E:
Nausea
Mx: take with meal
• Use:
IBS-C
Chronic idiopathic condition
Opioid-induced constipation
Linaclotide
• (+) Activate guanylate cyclase → ↑ Increase cGMP levels → ↑ Increase secretion of Cl⁻ and HCO₃⁻
• Use: CIC & IBS-C
IBS-DIARRHEA
Eluxadoline
Rifaximin
Alosetron
Crofelemer
Eluxadoline
• (+) Activates mu (μ) receptors = lead to decreased peristalsis
Rifaximin
Antibiotic with minimal systemic absorption - reduce overgrowth of bacteria
Alosetron
• 5-HT 3 receptor blocker = decrease bowel tone = decrease peristalsis movement
• A/E: GI effects including ischemic colitis
• Use: IBS-D in females
Crofelemer
• MOA:
↓ Decrease chloride secretion = ↓ Decrease sodium and water excretion
Helps maintain fluid balance and reduce diarrhea
• Use: Chronic Diarrhea in HIV/AIDS
• Can cause Hypovolemia (may be fatal)
Inflammatory Bowel Diseases
Ulcerative colitis
Crohn’s Disease
Ulcerative colitis
• Inflammation of GI mucosa
• Limited to the colon and rectum
Crohn’s Disease
• Inflammation is transmural
• Occurs in any part of the GIT
Drugs for Inflammatory Bowel Diseases
GLUCOCORTICOIDS
AMINOSALICYLATES
IMMUNOSUPPRESSIVE AGENTS
GLUCOCORTICOIDS
Hydrocortisone
Budesonide (Uceris)
Hydrocortisone
Treatment of both ulcerative colitis and Crohn’s disease
Budesonide (Uceris)
Specifically indicated for the treatment of ulcerative colitis (rectal aerosol foam)
AMINOSALICYLATES
Sulfasalazine (sulfonamide compound)
Olsalazine (salicylate compound)
Sulfasalazine (sulfonamide compound)
• Sulfonamide compound converted to:
a. 5-ASA (mesalamine/mesalazine) - anti-inflammatory
b. Sulfapyridine - antibacterial
Olsalazine (salicylate compound)
Salicylate compound
Contains mesalamine